FDA.reportPublic FDA data

Ngenla 60 MG per 1.2 ML Pen Injector

RxCUI
2644529
RxNorm name
Ngenla 60 MG per 1.2 ML Pen Injector
Display name
Ngenla 60 MG per 1.2 ML Pen Injector
Full name
Ngenla 60 MG per 1.2 ML Pen Injector
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761184Ngenlasomatrogon-ghla351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NgenlaSOMATROGON-GHLAPfizer Laboratories Div Pfizer Inc06dce529-b741-4a1b-8842-3ad77be6e3082026-05-07Warnings, Adverse reactionsExact identifier
rxcui: 2644529

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
06dce529-b741-4a1b-8842-3ad77be6e308Ngenla 60 MG per 1.2 ML Pen InjectorSY12These highlights do not include all the information needed to use NGENLA safely and effectively. See full prescribing information for NGENLA. NGENLA (somatrogon-ghla) injection, for subcutaneous use Initial U.S. Approval: 202320260507
06dce529-b741-4a1b-8842-3ad77be6e308Ngenla 50 MG/ML per 1.2 ML Pen InjectorSY12These highlights do not include all the information needed to use NGENLA safely and effectively. See full prescribing information for NGENLA. NGENLA (somatrogon-ghla) injection, for subcutaneous use Initial U.S. Approval: 202320260507
06dce529-b741-4a1b-8842-3ad77be6e308Ngenla 60 MG in 1.2 ML Pen InjectorPSN12These highlights do not include all the information needed to use NGENLA safely and effectively. See full prescribing information for NGENLA. NGENLA (somatrogon-ghla) injection, for subcutaneous use Initial U.S. Approval: 202320260507
06dce529-b741-4a1b-8842-3ad77be6e3081.2 ML somatrogon-ghla 50 MG/ML Pen Injector [Ngenla]SBD12These highlights do not include all the information needed to use NGENLA safely and effectively. See full prescribing information for NGENLA. NGENLA (somatrogon-ghla) injection, for subcutaneous use Initial U.S. Approval: 202320260507